FDA
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada
-
-
-
-
-
-
-
Fennec Pharmaceuticals announces public offering of common shares
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
-
334,268 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


